These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rechallenge Following Clozapine-Associated Eosinophilia: A Case Report and Literature Review. Lally J; OʼConnor N; Fullam S; Corcoran N; OʼReilly A; Jordan J; Guerandel A J Clin Psychopharmacol; 2019; 39(5):504-506. PubMed ID: 31335444 [No Abstract] [Full Text] [Related]
5. Clozapine associated neutropenia and cytomegalovirus colitis. Verbeeck WJ; Berk M Pharmacopsychiatry; 1998 Nov; 31(6):236-7. PubMed ID: 9930639 [TBL] [Abstract][Full Text] [Related]
6. Salivary flow rate in patients with schizophrenia on clozapine. Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023 [TBL] [Abstract][Full Text] [Related]
7. Successful challenge with clozapine in a history of eosinophilia. Schuepbach D; Merlo MC; Kaeser L; Brenner HD Int Clin Psychopharmacol; 1998 Jan; 13(1):33-7. PubMed ID: 9988365 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapine. Schmidinger S; Hofer A J Clin Psychopharmacol; 2014 Jun; 34(3):385-7. PubMed ID: 24717250 [No Abstract] [Full Text] [Related]
9. The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care, recognition and management. Garlipp P; Rosenthal O; Haltenhof H; Machleidt W J Psychopharmacol; 2002 Dec; 16(4):399-400. PubMed ID: 12503844 [TBL] [Abstract][Full Text] [Related]